The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Idorsia - Key investment highlights
Our strategic priorities
+ Unlocking the value of QUVIVIQ
+ Nurturing our existing alliances
+ Leveraging our innovative pipeline
+ Targeting our drug discovery
+ Making the money last
Find out more about the key priorities that management has set in order to develop Idorsia into one of Europe’s leading biopharmaceutical companies.
Our Portfolio
We have a diversified and balanced portfolio covering multiple therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
For investors, we provide more information on how Idorsia is innovating to change treatment paradigms in our innovation fact sheet.
